Home » Topics » Conferences

Conferences
RSS

Report of ThromboSol efficacy presented at hematology congress

Jan. 9, 1998

New rationale elucidated for clinical evaluation of GW-506U in refractory hematologic malignancies

Jan. 9, 1998

Phase II results presented for BB-10010

Jan. 8, 1998

Vasoflux preclinical data presented at major hematology congress

Jan. 8, 1998

Efficacy of recombinant hirudin demonstrated in patients with DIC

Jan. 8, 1998

Lilly discovers potent, selective and orally active beta3 agonists for diabetes, obesity

Jan. 2, 1998

New class of orally active bradykinin B2 antagonists presented by Fujisawa

Jan. 2, 1998

Banyu searches for potent, orally bioavailable FXa inhibitors

Dec. 31, 1997

FR-208419: a new dual CCK-A and CCK-B/gastrin receptor antagonist

Dec. 31, 1997

Lilly develops compounds for the common cold; selects development candidate

Dec. 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...